0,952  0,002  Sigma receptor antagonist
0,934  0,001  Sigma 2 receptor antagonist
0,922  0,002  Sigma 1 receptor antagonist
0,899  0,002  Cocaine dependence treatment
0,848  0,005  Analgesic
0,810  0,002  Opioid antagonist
0,792  0,003  NMDA 2 receptor antagonist
0,784  0,003  NMDA receptor antagonist
0,780  0,002  Opioid mu receptor antagonist
0,761  0,002  Sigma receptor agonist
0,753  0,001  NMDA receptor phencyclidine site antagonist
0,749  0,004  Muscle relaxant
0,720  0,002  Opioid delta receptor antagonist
0,716  0,004  Ulceration
0,714  0,003  Analgesic, opioid
0,714  0,005  Dependence treatment
0,709  0,003  Skeletal muscle relaxant
0,698  0,002  Opioid kappa receptor antagonist
0,687  0,007  Spasmolytic
0,677  0,003  Opioid agonist
0,640  0,002  Opioid mu receptor agonist
0,616  0,002  NMDA 2A receptor antagonist
0,610  0,003  NMDA 2C receptor antagonist
0,598  0,004  Toxic, respiratory center
0,585  0,001  Narcotic antagonist
0,594  0,018  Respiratory analeptic
0,583  0,016  5 Hydroxytryptamine release stimulant
0,558  0,003  Constipation treatment
0,545  0,007  Sedative
0,537  0,021  Stroke treatment
0,515  0,003  CNS active muscle relaxant
0,515  0,010  Psychostimulant
0,521  0,018  Cardiovascular analeptic
0,502  0,007  Anesthetic
0,520  0,027  Antipruritic, allergic
0,495  0,004  Nav1.1 sodium channel blocker
0,489  0,005  Pneumotoxic
0,494  0,016  CYP2D6 inhibitor
0,496  0,023  Analeptic
0,476  0,005  Nav1.2 sodium channel blocker
0,505  0,037  Antiparkinsonian
0,478  0,012  Acute neurologic disorders treatment
0,492  0,026  CYP2D6 substrate
0,483  0,022  UGT1A9 substrate
0,482  0,033  Mood disorders treatment
0,446  0,006  Cholinergic antagonist
0,445  0,011  UGT1A4 substrate
0,438  0,007  Antialcoholic
0,441  0,013  UGT1A1 substrate
0,433  0,006  Acetylcholine antagonist
0,464  0,048  CYP3A4 substrate
0,426  0,013  Anesthetic general
0,445  0,037  Antidepressant
0,441  0,035  Antipsychotic
0,429  0,029  Sensitization
0,399  0,003  Opioid delta receptor agonist
0,400  0,005  Acetylcholine M1 receptor antagonist
0,397  0,002  Opioid kappa receptor agonist
0,397  0,004  Dopamine D1 antagonist
0,394  0,005  Antiinfertility, female
0,394  0,009  Tyrosine 3 hydroxylase inhibitor
0,389  0,004  Nav1.6 sodium channel blocker
0,388  0,007  Antipruritic
0,412  0,035  NOS3 expression inhibitor
0,375  0,005  Nav1.3 sodium channel blocker
0,365  0,005  Acetylcholine muscarinic antagonist
0,433  0,092  Caspase 9 stimulant
0,339  0,017  Prostatic (benign) hyperplasia treatment
0,338  0,019  UGT2B7 substrate
0,327  0,016  Prostate disorders treatment
0,319  0,010  Dopamine D2 antagonist
0,319  0,014  Neurotrophic factor enhancer
0,310  0,011  Dopamine antagonist
0,304  0,010  UGT2B9 substrate
0,313  0,022  5 Hydroxytryptamine 1E antagonist
0,361  0,073  Cognition disorders treatment
0,323  0,038  UGT1A6 substrate
0,301  0,021  UGT1A3 substrate
0,317  0,037  5 Hydroxytryptamine uptake stimulant
0,329  0,050  UGT2B4 substrate
0,287  0,010  Alpha 2b adrenoreceptor antagonist
0,281  0,007  Alpha 2c adrenoreceptor antagonist
0,325  0,056  Teratogen
0,329  0,066  AR expression inhibitor
0,311  0,048  Cardiodepressant
0,282  0,020  Antiparkinsonian, tremor relieving
0,270  0,014  LDLR expression enhancer
0,268  0,013  Glutamate receptor antagonist
0,312  0,068  Sodium/bile acid cotransporter inhibitor
0,244  0,004  Dopamine D5 antagonist
0,252  0,013  VEGF expression inhibitor
0,304  0,065  CYP2C19 substrate
0,264  0,028  Contraceptive
0,261  0,027  Irritable Bowel syndrome treatment
0,238  0,005  Acetylcholine M2 receptor antagonist
0,297  0,066  FMO3 substrate
0,274  0,045  Antiarrhythmic
0,299  0,072  CTGF expression inhibitor
0,288  0,062  Embryotoxic
0,261  0,035  Male reproductive disfunction treatment
0,227  0,005  Prolactin inhibitor
0,241  0,022  Anesthetic local
0,259  0,046  UDP-glucuronosyltransferase substrate
0,224  0,013  UGT2B1 substrate
0,246  0,036  Antipruritic, non-allergic
0,222  0,016  Endometrios treatment
0,214  0,009  Dopamine agonist
0,248  0,048  Abortion inducer
0,269  0,071  Flavin-containing monooxygenase substrate
0,268  0,071  Antihypercholesterolemic
0,315  0,120  TNF expression inhibitor
0,225  0,034  UGT2B15 substrate
0,253  0,065  Potassium channel (Voltage-sensitive) blocker
0,245  0,058  Antiparkinsonian, rigidity relieving
0,204  0,024  Antitussive
0,228  0,049  P-glycoprotein inhibitor
0,246  0,068  HERG channel blocker
0,189  0,012  5 Hydroxytryptamine uptake inhibitor
0,205  0,033  UGT2B10 substrate
0,232  0,064  Anticonvulsant
0,195  0,028  Cholesterol synthesis inhibitor
0,192  0,028  5 Hydroxytryptamine 2B antagonist
0,172  0,012  Toll-Like receptor 4 antagonist
0,192  0,034  SULT1A3 substrate
0,172  0,017  Estrogen antagonist
0,305  0,153  Calcium channel L-type activator
0,168  0,019  Alpha 2a adrenoreceptor antagonist
0,170  0,023  Alpha 2 adrenoreceptor antagonist
0,149  0,006  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,152  0,010  Dopamine uptake inhibitor
0,179  0,038  Neurotrophic factor
0,161  0,020  Multidrug resistance-associated protein 1 inhibitor
0,147  0,006  Dopamine transporter inhibitor
0,159  0,018  Acetylcholine nicotinic antagonist
0,206  0,065  Nitric oxide antagonist
0,184  0,044  Antidiarrheal
0,143  0,007  Dopamine D2 agonist
0,279  0,146  CYP2C19 inhibitor
0,269  0,140  Antiobesity
0,181  0,053  Diuretic
0,141  0,016  Dopamine D3 antagonist
0,138  0,014  Estrogen receptor alpha antagonist
0,156  0,032  SULT1A1 substrate
0,213  0,090  Antihypotensive
0,168  0,047  Antifungal enhancer
0,234  0,115  Hypoxia-inducible factor 1 alpha inhibitor
0,137  0,020  SULT1E1 substrate
0,151  0,035  Antiadrenergic
0,243  0,127  Interleukin 2 agonist
0,163  0,048  Acetylcholinesterase inhibitor
0,209  0,095  NOS2 expression inhibitor
0,135  0,025  Alpha 1b adrenoreceptor antagonist
0,215  0,106  Cardiotonic
0,121  0,013  SULT1A2 substrate
0,143  0,036  Adrenaline antagonist
0,168  0,064  Cholinergic
0,177  0,073  Lipocortins synthesis antagonist
0,107  0,004  Prolactin release inhibitor
0,108  0,006  SULT2A1 substrate
0,127  0,025  Estrogen receptor beta antagonist
0,132  0,032  5 Hydroxytryptamine 2C antagonist
0,147  0,049  Antismoking
0,237  0,140  Apoptosis antagonist
0,140  0,043  Contraceptive female
0,112  0,016  Adrenaline uptake inhibitor
0,180  0,084  Antimigraine
0,099  0,004  Vesicle monoamine transporter inhibitor
0,109  0,014  CC chemokine 5 receptor agonist
0,150  0,057  Psychosexual dysfunction treatment
0,124  0,031  UGT2B11 substrate
0,110  0,024  Nicotinic alpha4beta2 receptor antagonist
0,112  0,026  5 Hydroxytryptamine 1F antagonist
0,107  0,022  Neuronal nicotinic receptor antagonist
0,242  0,157  CYP2C9 substrate
0,156  0,071  Interferon gamma antagonist
0,090  0,007  Nociceptin (N/OFQ) receptor antagonist
0,134  0,051  5 Hydroxytryptamine 2 antagonist
0,115  0,034  Histamine H1 receptor antagonist
0,240  0,160  Calcium channel activator
0,212  0,133  Prostate cancer treatment
0,111  0,032  Restless leg syndrome treatment
0,122  0,046  Alpha adrenoreceptor antagonist
0,267  0,197  Apoptosis agonist
0,182  0,115  Aldehyde oxidase inhibitor
0,090  0,026  Alpha 1d adrenoreceptor antagonist
0,159  0,098  Sleep disorders treatment
0,111  0,051  Antiemetic
0,068  0,009  Dopamine D5 agonist
0,088  0,030  Dopamine D4 antagonist
0,145  0,089  Melanin inhibitor
0,190  0,135  Antiosteoporotic
0,108  0,055  Antihypermotility
0,093  0,042  Antiprotozoal activity enhancer
0,105  0,056  Anabolic
0,074  0,025  Estrogen agonist
0,125  0,077  Antihemorrhagic
0,131  0,083  Lipid peroxidase inhibitor
0,077  0,030  5 Hydroxytryptamine 2A agonist
0,099  0,052  ABCA1 expression enhancer
0,069  0,022  Postcoital contraceptive
0,142  0,097  Uterine stimulant
0,104  0,059  Butyrylcholinesterase inhibitor
0,088  0,044  Estrogen-related receptor beta agonist
0,135  0,091  NOS3 expression enhancer
0,047  0,004  Vesicular acetylcholine transporter inhibitor
0,141  0,099  Arachidonic acid antagonist
0,080  0,039  Glycine receptor agonist
0,127  0,089  Farnesoid X receptor antagonist
0,111  0,075  DNA polymerase I inhibitor
0,071  0,036  5 Hydroxytryptamine 7 antagonist
0,132  0,097  Adenylate cyclase stimulant
0,215  0,182  Immunosuppressant
0,185  0,152  Chemoprotective
0,067  0,034  Acetylcholine M5 receptor antagonist
0,098  0,066  Chronic obstructive bronchitis treatment
0,078  0,047  Cushing's syndrome treatment
0,036  0,006  Dopamine D1 agonist
0,065  0,037  5 Hydroxytryptamine 5A antagonist
0,080  0,053  Alpha 1 adrenoreceptor antagonist
0,123  0,096  Antiischemic, cerebral
0,069  0,042  5 Hydroxytryptamine 1B antagonist
0,060  0,033  Postmenopausal disorders treatment
0,074  0,048  Alpha 1a adrenoreceptor antagonist
0,089  0,065  Antihistaminic
0,071  0,050  Calcium channel L-type blocker
0,080  0,059  5 Hydroxytryptamine 2A antagonist
0,086  0,064  Contraceptive male
0,059  0,038  Lipocortins synthesis agonist
0,087  0,067  Paget's disease treatment
0,166  0,146  Antioxidant
0,041  0,021  Estrogen receptor beta agonist
0,047  0,027  Nicotinic receptor alpha3 subunit antagonist
0,196  0,178  ICAM1 expression inhibitor
0,194  0,175  Transcription factor NF kappa B inhibitor
0,098  0,080  DOPA decarboxylase inhibitor
0,056  0,038  Sphingosine kinase 2 inhibitor
0,054  0,036  Nicotinic alpha3beta2 receptor antagonist
0,038  0,022  Estrogen receptor alpha agonist
0,059  0,043  Acetylcholine M3 receptor antagonist
0,151  0,135  Potassium channel blocker
0,091  0,075  Sulfotransferase substrate
0,053  0,038  Nicotinic receptor alpha7 subunit antagonist
0,044  0,030  Liver X receptor agonist
0,085  0,072  Breast cancer-resistant protein inhibitor
0,064  0,051  Hypercalcemia treatment
0,076  0,064  Adrenaline agonist
0,037  0,026  Nicotinic receptor beta4 subunit antagonist
0,077  0,067  Histamine antagonist
0,078  0,068  Antineoplastic alkaloid
0,055  0,046  5 Hydroxytryptamine 5 antagonist
0,186  0,177  Cholesterol antagonist
0,119  0,111  Genotoxic
0,030  0,024  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,065  0,058  5 Hydroxytryptamine 1 antagonist
0,127  0,122  Cytotoxic
0,028  0,025  Glucocorticoid antagonist
0,155  0,152  Tumour necrosis factor alpha release inhibitor
0,058  0,055  5 Hydroxytryptamine 1A antagonist
0,056  0,054  5 Hydroxytryptamine 1D antagonist
0,111  0,109  Papain-like protease (SARS coronavirus) inhibitor
0,162  0,160  Lipoprotein disorders treatment
0,074  0,073  Androgen antagonist

